Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New combo aims to shrink head and neck tumors, sparing patients from disfiguring surgery

NCT ID NCT07209189

First seen Nov 01, 2025 · Last updated Apr 29, 2026 · Updated 39 times

Summary

This study tests whether giving chemotherapy and immunotherapy before standard surgery can shrink head and neck tumors enough to allow less extensive, function-preserving surgery. It enrolls 75 adults with newly diagnosed advanced head and neck cancer, including HPV-related and HPV-unrelated types. The goal is to reduce the need for radical surgery that can affect swallowing, speech, and vision, while still controlling the cancer.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SQUAMOUS CELL CARCINOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Johns Hopkins Hospital East Baltimore

    RECRUITING

    Baltimore, Maryland, 21287, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.